Citation Impact
Citing Papers
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
Androgen-Induced Differentiation and Tumorigenicity of Human Prostate Epithelial Cells
2004
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
2009 StandoutNobel
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial
2007 Standout
High level PSMA expression is associated with early psa recurrence in surgically treated prostate cancer
2010
PET imaging of cyclooxygenase-2 (COX-2) in a pre-clinical colorectal cancer model
2016
Cancer–stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis
2012 StandoutNobel
In situ click chemistry generation of cyclooxygenase-2 inhibitors
2017 Standout
MET and VEGF: synergistic targets in castration-resistant prostate cancer
2011
Multicenter ProstaScint imaging findings in 2154 patients with prostate cancer
2000
Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors
2008 Standout
The Proteome of Primary Prostate Cancer
2015
MYC on the Path to Cancer
2012 Standout
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2014 Standout
Thrombospondin-1 expression in patients with pathologic stage T3 prostate cancer undergoing radical prostatectomy: association with p53 alterations, tumor angiogenesis, and tumor progression
2002
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
OCT4 Staining in Testicular Tumors
2004
Naked DNA and Adenoviral Immunizations for Immunotherapy of Prostate Cancer: A Phase I/II Clinical Trial
2000
Clinical Trials of Cancer Therapies Targeting Prostate-Specific Membrane Antigen
2007
Dosimetry of 177Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: Correlations Between Pretherapeutic Imaging and Whole-Body Tumor Dosimetry with Treatment Outcomes
2018
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma
2005 StandoutNature
Prostate-targeted radiosensitization via aptamer-shRNA chimeras in human tumor xenografts
2011
A colorful future of quantitative pathology: validation of Vectra technology using chromogenic multiplexed immunohistochemistry and prostate tissue microarrays
2012
Epidemiology of prostate cancer
1997
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
2013 Standout
Brachytherapy for carcinoma of the prostate: Techniques, patient selection, and clinical outcomes
2002
Pathological and molecular aspects of prostate cancer
2003
68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0
2017
Nucleolar Grade But Not Fuhrman Grade is Applicable to Papillary Renal Cell Carcinoma
2006
Molecular determinants of resistance to antiandrogen therapy
2003 Standout
DETECTION OF DISSEMINATED TUMOR CELLS IN PERIPHERAL BLOOD
2005
Alterations in Nucleolar Structure and Gene Expression Programs in Prostatic Neoplasia Are Driven by the MYC Oncogene
2011
ICUD-EAU International Consultation on Bladder Cancer 2012: Pathology
2012
Cellpose 2.0: how to train your own model
2022 Standout
Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer
2003 Standout
Isolation of rare circulating tumour cells in cancer patients by microchip technology
2007 StandoutNature
Nonurothelial Bladder Cancer and Rare Variant Histologies
2015
The development of androgen-independent prostate cancer
2001 Standout
Phage-encoded combinatorial chemical libraries based on bicyclic peptides
2009 StandoutNobel
CTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model systems
2004 StandoutNobel
In vivo cancer targeting and imaging with semiconductor quantum dots
2004 Standout
Aptamers as therapeutics
2010 Standout
The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma
2005 Standout
Certain Aspects of Molecular Endocrinology That Relate to the Influence of Dietary Factors on the Pathogenesis of Prostate Cancer
1999
The biochemistry and medical significance of the flavonoids
2002 Standout
Testicular germ-cell tumours in a broader perspective
2005 Standout
The Perseus computational platform for comprehensive analysis of (prote)omics data
2016 Standout
Novel Peptide Inhibitors of Human Kallikrein 2
2006
Aptamers as targeted therapeutics: current potential and challenges
2016 Standout
Histologic variants of urothelial carcinoma: differential diagnosis and clinical implications
2006
Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study
2008
Bladder cancer
2016 Standout
Translation of new cancer treatments from pet dogs to humans
2008 Standout
Prevalence of prostate cancer and prostatic intraepithelial neoplasia in Caucasian Mediterranean males: An autopsy study
2002
The impact of variant histology on the outcome of bladder cancer treated with curative intent
2008
Molecular genetics of prostate cancer
2000
Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implications
2009
Phase IIA Clinical Trial to Test the Efficacy and Safety of Toremifene in Men with High-Grade Prostatic Intraepithelial Neoplasia
2003
Strategies in the design of nanoparticles for therapeutic applications
2010 Standout
Changes in Biomarker Expression in the Development of Prostatic Adenocarcinoma
1997
Immunotherapy for prostate cancer
2006
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
The roles of PTEN in development, physiology and tumorigenesis in mouse models: a tissue-by-tissue survey
2008 StandoutNobel
A combined approach to data mining of textual and structured data to identify cancer-related targets
2006
Androgen receptor as a target in androgen-independent prostate cancer
2002
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
2005 StandoutNature
Is prostate-specific membrane antigen a multifunctional protein?
2005
What Is the Significance of Variant Histology in Urothelial Carcinoma?
2019
mRNA vaccine CV9103 and CV9104 for the treatment of prostate cancer
2014
[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study
2018
Metastatic renal cell carcinoma neovasculature expresses prostate-specific membrane antigen
2001
The clinical role of prostate-specific membrane antigen (PSMA)
2002
Nonmetastatic renal-cell carcinoma: is it really possible to define rational guidelines for post-treatment follow-up?
2006
p63, a p53 Homolog at 3q27–29, Encodes Multiple Products with Transactivating, Death-Inducing, and Dominant-Negative Activities
1998 Standout
Perineural Invasion, Mucinous Fibroplasia, and Glomerulations
1999
OCT4
2004
Nanoparticle and targeted systems for cancer therapy
2004 Standout
The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor Lesions
2015
The emerging roles of human tissue kallikreins in cancer
2004
A phase I study of cabozantinib (XL184) in patients with renal cell cancer
2014 StandoutNobel
Protein therapeutics: a summary and pharmacological classification
2007 Standout
High-Grade Prostatic Intraepithelial Neoplasia in Dogs
1999
Resveratrol Suppresses TNF-Induced Activation of Nuclear Transcription Factors NF-κB, Activator Protein-1, and Apoptosis: Potential Role of Reactive Oxygen Intermediates and Lipid Peroxidation
2000 Standout
Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens
2005
THE RELATIVE IMPACT AND FUTURE BURDEN OF PROSTATE CANCER IN THE UNITED STATES
2004
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
A Mitochondrial Paradigm of Metabolic and Degenerative Diseases, Aging, and Cancer: A Dawn for Evolutionary Medicine
2005 Standout
Increased Expression of Genes Converting Adrenal Androgens to Testosterone in Androgen-Independent Prostate Cancer
2006 Standout
SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade
2008 StandoutNobel
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
2015 Standout
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
Imaging of Prostate-Specific Membrane Antigen with Small-Molecule PET Radiotracers: From the Bench to Advanced Clinical Applications
2019
Bladder Cancer
2020 Standout
Antioxidant enzyme expression and reactive oxygen species damage in prostatic intraepithelial neoplasia and cancer
2000
Sunflower trypsin inhibitor (SFTI-1) analogues of synthetic and biological origin via N→S acyl transfer: potential inhibitors of human Kallikrein-5 (KLK5)
2014 StandoutNobel
Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
2021 Standout
Androgen-Independent Prostate Cancer Is a Heterogeneous Group of Diseases
2004
A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.
2001
Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen.
2001
Hoxb13is required for normal differentiation and secretory function of the ventral prostate
2003 StandoutNobel
Prostate stem cell antigen: A cell surface marker overexpressed in prostate cancer
1998
Targeting Metastatic Prostate Cancer With Radiolabeled Monoclonal Antibody J591 to the Extracellular Domain of Prostate Specific Membrane Antigen
2003
Prostate-specific membrane antigen is produced in tumor-associated neovasculature.
1999
The Sensitivity of Initial Transurethral Resection or Biopsy of Bladder Tumor(s) for Detecting Bladder Cancer Variants on Radical Cystectomy
2012
Quercetin inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells
2001
Multifunctional Nanoparticles: Cost Versus Benefit of Adding Targeting and Imaging Capabilities
2012 Science
Preclinical Evaluation of Novel Glutamate-Urea-Lysine Analogues That Target Prostate-Specific Membrane Antigen as Molecular Imaging Pharmaceuticals for Prostate Cancer
2009
Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten
2004 StandoutNobel
Works of Anna Pacelli being referenced
Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma
1998
High grade prostatic intraepithelial neoplasia in military working dogs with and without prostate cancer
1998
Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases
1998
Prostatic adenocarcinoma with glomeruloid features
1998
Human glandular kallikrein 2 expression in prostate adenocarcinoma and lymph node metastases
1999
Role of microvessel density in predicting recurrence in pathologic stage T3 prostatic adenocarcinoma
1999
Intestinal metaplasia is not a strong risk factor for bladder cancer: Study of 53 cases with long-term follow-up
1997
Grading of renal cell carcinoma
1997
Clinical significance of high-grade prostatic intraepithelial neoplasia in transurethral resection specimens
1997
Molecular biology of prostatic intraepithelial neoplasia
1996
Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: A novel prostate cancer marker
1997
Ultrastructure of prostatic intraepithelial neoplasia
1997
p53 Protein overexpression is associated with increased cell proliferation in patients with locally recurrent prostate carcinoma after radiation therapy
1999
Neuroendocrine expression in node positive prostate cancer: correlation with systemic progression and patient survival.
2002
The radial distance of extraprostatic extension of prostatic adenocarcinoma: Implications for prostate brachytherapy
1998
ANDROGEN RECEPTOR EXPRESSION IN PROSTATE CANCER LYMPH NODE METASTASES IS PREDICTIVE OF OUTCOME AFTER SURGERY
1999
CARCINOSARCOMA AND SARCOMATOID CARCINOMA OF THE BLADDER: CLINICOPATHOLOGICAL STUDY OF 41 CASES
1998
p53 Alteration in regional lymph node metastases from prostate carcinoma
1999
ANDROGEN RECEPTOR EXPRESSION IN PROSTATIC INTRAEPITHELIAL NEOPLASIA AND CANCER
1999
Imaging COX‐2 expression in cancer using PET/SPECT radioligands: current status and future directions
2013
Neuroendocrine Expression in Node Positive Prostate Cancer: Correlation With Systemic Progression and Patient Survival
2002